A 34-year-old patient with osteogenesis imperfecta (OI) underwent previous double-valve
replacement in the aortic and mitral valve position. Bioprostheses were implanted
because of an elevated risk of daily injury. Five years later the patient underwent
re-replacement of the stenotic stentless mitral valve prosthesis. A right anterolateral
mini-thoracotomy was used for operative access during both procedures, in order to
preserve thorax stability. Patients with OI may benefit from minimally invasive valve
surgery for primary procedures or reoperation.
Heart valve surgery - heart disease - thoracic surgery